Customer Support: +919024236503

Need Help?

  • Share via whatsapp

Enalapril Maleate 5 mg

Jun 28, 2022

Enalapril Maleate 5 mg, a commonly used angiotensin-converting enzyme (ACE) inhibitor, is found in ENALAPRIME 5, a prescription drug used to treat heart failure and hypertension. Enalapril relaxes blood vessels, lowers blood pressure, and lessens cardiac strain by preventing the conversion of angiotensin I to angiotensin II, a strong vasoconstrictor.

Patients with hypertension, heart failure, diabetic nephropathy, or left ventricular dysfunction benefit most from ENALAPRIME 5's cardioprotective and renoprotective properties. Healthcare professionals can titrate therapy in accordance with clinical response and tolerance thanks to the safe beginning dose of 5 mg.

Uses

ENALAPRIME 5 is indicated for multiple cardiovascular and renal conditions:

1. Hypertension (High Blood Pressure)

Enalapril effectively lowers elevated blood pressure, reducing the risk of stroke, heart attack, and kidney complications. It can be used as monotherapy or in combination with other antihypertensive agents to achieve target blood pressure.

2. Heart Failure

In patients with symptomatic heart failure, ENALAPRIME 5 reduces mortality, hospitalization, and disease progression by decreasing cardiac workload and improving ventricular function.

3. Left Ventricular Dysfunction

Enalapril is beneficial in patients with asymptomatic or symptomatic left ventricular dysfunction, helping to prevent remodeling and progression to heart failure.

4. Diabetic Nephropathy

ENALAPRIME 5 slows progression of kidney damage in patients with type 1 or type 2 diabetes, particularly those with proteinuria, by reducing intraglomerular pressure.

5. Combination Therapy

Enalapril may be used alongside diuretics, beta-blockers, or calcium channel blockers for patients requiring multi-drug therapy to achieve optimal cardiovascular outcomes.

Through these indications, ENALAPRIME 5 provides comprehensive cardiovascular and renal management, making it a reliable option for high-risk patients.

Benefits

ENALAPRIME 5 offers multiple clinical and patient-centered advantages:

1. Effective Blood Pressure Control

By inhibiting angiotensin II formation, Enalapril promotes vasodilation and reduced peripheral resistance, effectively lowering blood pressure and protecting cardiovascular health.

2. Cardioprotective Effects

ENALAPRIME 5 helps reduce mortality and morbidity in heart failure, prevents left ventricular hypertrophy, and decreases the risk of myocardial infarction and stroke.

3. Renoprotective Effects

The medication slows progression of kidney disease in diabetic and hypertensive patients by reducing proteinuria and preserving renal function.

4. Once- or Twice-Daily Dosing

The 5 mg tablet allows for flexible dosing, enhancing patient adherence while maintaining effective therapy.

5. Well-Tolerated Therapy

ENALAPRIME 5 is generally safe and well-tolerated, with most adverse effects being mild and transient, such as cough or dizziness.

6. Evidence-Based Efficacy

Clinical studies consistently demonstrate that Enalapril reduces blood pressure, prevents heart failure progression, and protects renal function, making ENALAPRIME 5 a cornerstone in cardiovascular management.

These benefits make ENALAPRIME 5 a trusted, effective, and patient-friendly therapy for managing hypertension, heart failure, and kidney complications.

Dosage

The dosage of ENALAPRIME 5 should be individualized based on patient condition, kidney function, blood pressure, and response to therapy.

Recommended Dosage:

  • Typical Starting Dose: One tablet of ENALAPRIME 5 mg once daily.

  • Administration: Swallow the tablet with water, preferably at the same time each day, with or without food.

Dose Adjustment:

  • Dose may be titrated up to 20–40 mg daily in divided doses, depending on clinical response and tolerability.

  • Patients with renal impairment or elderly patients may require a lower starting dose or careful monitoring.

  • Regular monitoring of blood pressure, kidney function, and serum potassium is recommended during therapy.

Adherence to the prescribed dosage ensures maximum efficacy and safety.

Side Effects

ENALAPRIME 5 is generally well-tolerated, but some patients may experience side effects:

Common Side Effects:

  • Persistent dry cough

  • Dizziness or lightheadedness

  • Fatigue or weakness

  • Headache

  • Mild gastrointestinal disturbances, including nausea or diarrhea

Less Common but Serious Side Effects:

  • Hyperkalemia (high potassium levels)

  • Severe hypotension, particularly in volume-depleted patients

  • Worsening kidney function in susceptible individuals

  • Rare allergic reactions, including angioedema, facial swelling, or difficulty breathing

Patients experiencing severe dizziness, swelling of face or throat, or irregular heartbeat should seek immediate medical attention.

Precautions and Warning

Before initiating ENALAPRIME 5, healthcare providers should consider the following precautions:

1. Kidney Function Monitoring

Monitor serum creatinine and kidney function, especially in patients with pre-existing renal disease, bilateral renal artery stenosis, or elderly patients.

2. Electrolyte Monitoring

Regular monitoring of serum potassium is necessary to prevent hyperkalemia.

3. Blood Pressure Monitoring

Monitor for hypotension, particularly in volume-depleted or critically ill patients.

4. Pregnancy and Lactation

ENALAPRIME 5 is contraindicated in pregnancy, particularly during the second and third trimesters, due to potential fetal toxicity.

5. Drug Interactions

Inform your healthcare provider about other medications, including diuretics, NSAIDs, potassium supplements, or other antihypertensives.

6. Lifestyle Considerations

Patients should maintain hydration, adhere to dietary guidelines, and promptly report unusual symptoms.

By following these precautions, ENALAPRIME 5 can be used safely and effectively in long-term therapy.

Conclusion

ENALAPRIME 5, containing Enalapril Maleate 5 mg, is a clinically proven ACE inhibitor that provides effective blood pressure control, heart failure management, and renal protection. By inhibiting angiotensin II formation, it promotes vasodilation, reduces cardiac workload, and preserves kidney function, making it an essential therapy for patients with hypertension, heart failure, and diabetic nephropathy.

With flexible dosing, once- or twice-daily administration, and a favorable safety profile, ENALAPRIME 5 is a reliable choice for healthcare providers in India seeking to deliver long-term cardiovascular and renal protection. When combined with lifestyle modifications, dietary measures, and regular monitoring, it ensures improved patient outcomes, reduced risk of complications, and enhanced quality of life.

SHARE WITH

  • Share via whatsapp